Lobbying Filing Details
Total Spending
$60,000
Activities
3
Lobbyists
3
Gov't Entities
6
Filing Information
- Filing UUID:
2cff6643-964d-43b4-9c7e-a62dfd8e75d6- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 18, 2026 at 6:11 PM
- Income:
- $60,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Jonathon Jones, Partner
Registrant
TIBER CREEK GROUP
Government Relations.
Washington, District of ColumbiaClient
ORGANON, LLC
Pharmaceutical Company.
District of Columbia, United States of AmericaLobbying Activities (3)
Activity 1
Budget/AppropriationsIssues related to women's health.
Lobbyists (3)
- EMILY KIRLIN
- MATTHEW LEFFINGWELL
- COREY MALMGREN
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
Health IssuesIssues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Lobbyists (3)
- EMILY KIRLIN
- MATTHEW LEFFINGWELL
- COREY MALMGREN
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Medicare/MedicaidIssues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Lobbyists (3)
- EMILY KIRLIN
- MATTHEW LEFFINGWELL
- COREY MALMGREN
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES